How A Drugmaker Gamed The System To Keep Generic Competition Away
(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read More
Month: May 2018
CMS is initiating a National Coverage Analysis for CAR-T therapies
In 2017, the Food and Drug Administration approved the first chimeric antigen receptor (CAR)-T cell therapies, now the Centers for
Read MoreCMS unveils $25B quality improvement program
(By Megan Knowles for Becker’s Hospital Review) CMS seeks to combine various Medicare quality improvement programs under a single contract
Read MoreGAO: Medical records are still too challenging to obtain — 7 things to know
(By Julie Spitzer for Becker’s Hospital Review) Despite a HIPAA-granted right to their own medical records, patients still struggle to
Read MoreIn a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal
(By Lev Facher for STAT) WASHINGTON — The Food and Drug Administration on Wednesday approved for the first time a
Read MoreChanges to Medicare Part D for 2019
When the President signed the Bipartisan Budget Act of 2018 on February 9th, this legislation affected those individuals with Medicare
Read MoreTest of Herceptin Finds Briefer Treatment Can Work, With Fewer Side Effects
(By Richard Harris for NPR) Sometimes less may be better when it comes to treatment for breast cancer. A new
Read MoreThe Senate calling into question the 340B Drug Pricing Program
The United States Senate Committee on Health, Education, Labor and Pensions (HELP) is calling into question the intent of 340B
Read MoreIRS releases new limits on Health Savings Accounts for 2019
The Internal Revenue Service (IRS) announced cost-of-living adjustments for health savings accounts (HSAs) and high-deductible health plans (HDHPs) for 2019.
Read MoreFeds won’t approve lifetime limits on Medicaid
(By Leo Vartorella for Becker’s Hospital Review) CMS does not plan to approve state requests to impose lifetime limits on
Read More